Niranib 100mg Capsule (Niraparib) Price in Pakistan | Impo Medic
₨ 68,000
Description
Niranib 100mg Capsule (Niraparib) Price in Pakistan
Niranib 100mg Capsule (Niraparib) is a prescription targeted oncology medicine used as maintenance treatment for eligible adults with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer. It belongs to a class of medicines called poly (ADP-ribose) polymerase (PARP) inhibitors. Niraparib works by blocking enzymes involved in repairing damaged DNA, which can interfere with the survival and growth of cancer cells. It is generally prescribed for patients whose cancer has shown a complete or partial response to platinum-based chemotherapy.
Niranib is manufactured by Everest Pharmaceuticals Ltd., Bangladesh. Each capsule contains 100mg of Niraparib, and the manufacturer’s listed pack size is 30 capsules in an HDPE container. This imported oncology medicine is intended for oral administration under the supervision of a qualified oncologist. Treatment suitability depends on the patient’s diagnosis, previous chemotherapy response, relevant clinical assessment and applicable prescribing guidelines.
Uses of Niraparib
Niraparib is prescribed as maintenance treatment for selected adults with certain ovarian-related cancers after a response to platinum-based chemotherapy. Its manufacturer-listed indication includes:
-
Ovarian Cancer: Maintenance treatment for eligible adults with recurrent epithelial ovarian cancer who have achieved a complete or partial response to platinum-based chemotherapy.
-
Fallopian Tube Cancer: May be prescribed for eligible patients with recurrent fallopian tube cancer following a response to platinum-based chemotherapy.
-
Primary Peritoneal Cancer: Used as maintenance treatment in selected patients with recurrent primary peritoneal cancer after responding to platinum-based chemotherapy.
The exact treatment decision depends on the patient’s cancer type, previous treatment, clinical condition and applicable local prescribing guidance. Niraparib is not suitable for every cancer patient and should only be prescribed by an oncology specialist.
How Niraparib Works
Niraparib inhibits PARP-1 and PARP-2 enzymes, which play an important role in repairing damaged DNA inside cells. Cancer cells may already have weaknesses in their DNA-repair pathways. By blocking PARP activity, Niraparib can increase DNA damage and interfere with the cancer cells’ ability to survive and multiply.
This mechanism is known as synthetic lethality. It helps explain why PARP inhibitors are used in selected cancer treatment plans, particularly as maintenance therapy after chemotherapy.
Dosage and Administration
The manufacturer’s reference dose for Niraparib monotherapy is generally 300mg once daily, equivalent to three 100mg capsules. However, the appropriate dose may vary according to the patient’s condition, blood counts, body weight, treatment tolerance and the prescribing specialist’s assessment.
-
Take Niranib exactly as prescribed by the oncologist.
-
Take the prescribed dose at approximately the same time each day.
-
Capsules may be taken with or without food.
-
Swallow capsules whole with water; do not crush or chew them.
-
If a dose is missed or vomiting occurs after taking it, do not take an additional dose. Follow the prescribed schedule.
The oncologist may reduce, interrupt or discontinue treatment if serious adverse reactions occur. Never change the dose independently.
Precautions
Niraparib requires regular medical monitoring because it can cause serious side effects. Patients should inform their doctor about existing medical conditions, pregnancy, breastfeeding and all medicines or supplements they use.
Important precautions include:
-
Blood cell abnormalities: Low platelet counts, anaemia and reduced white blood cells may occur. Regular complete blood count testing is essential.
-
MDS and AML: Myelodysplastic syndrome and acute myeloid leukaemia have been reported in patients receiving Niraparib.
-
Blood pressure: Hypertension and other cardiovascular effects may occur. Regular blood pressure and heart rate monitoring are recommended.
-
Neurological complications: Rare cases of posterior reversible encephalopathy syndrome (PRES) have been reported.
-
Pregnancy: Niraparib may harm an unborn baby. Discuss effective contraception with the treating specialist.
-
Breastfeeding: Breastfeeding should be avoided during treatment as advised by the prescribing information.
Possible side effects include nausea, fatigue, constipation, vomiting, abdominal discomfort, decreased appetite, headache, anaemia and changes in blood counts. Seek medical attention for unusual bleeding, persistent fever, severe headache or other concerning symptoms.
Product Information
-
Product Name: Niranib
-
Generic Name: Niraparib
-
Strength: 100mg
-
Dosage Form: Capsule
-
Pack Size: 30 Capsules
-
Manufacturer: Everest Pharmaceuticals Ltd.
-
Country of Manufacture: Bangladesh
-
Therapeutic Category: Targeted Oncology Medicine
-
Drug Class: PARP Inhibitor
-
Route of Administration: Oral
FAQs about Niranib 100mg Capsule (Niraparib) Price in Pakistan
1. What is Niranib 100mg Capsule used for?
Niranib is used as maintenance treatment for selected patients with recurrent ovarian, fallopian tube or primary peritoneal cancer after a response to platinum-based chemotherapy.
2. What is the generic name of Niranib?
The generic name is Niraparib. Each capsule contains 100mg of the active ingredient.
3. Who manufactures Niranib 100mg Capsule?
Niranib is manufactured by Everest Pharmaceuticals Ltd., Bangladesh.
4. How many capsules are included in one pack?
The manufacturer’s listed pack contains 30 capsules, each containing 100mg of Niraparib.
5. Is Niraparib available in Pakistan?
Availability depends on current stock and supply conditions. Contact Impo Medic to check Niranib availability and the current Niraparib 100mg price in Pakistan.
Niranib 100mg Capsule in Pakistan
Looking for Niranib price in Pakistan, Niranib 100mg price, Niraparib price, or Niraparib 100mg price? Contact Impo Medic to check current pricing and availability of Niranib 100mg Capsule. Manufactured by Everest Pharmaceuticals Ltd., Bangladesh, this imported oncology medicine is supplied in a pack of 30 capsules. Patients and healthcare professionals can enquire about Niranib availability in Pakistan and current stock before ordering. Use this prescription medicine only under the supervision of a qualified oncologist.

Reviews
There are no reviews yet.